Crossmark

An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa

Published Online: 2022-01-05

Published Print: 2022-12

Authors

Moshoeshoe, R. J. https://orcid.org/0000-0003-1145-9864
Enslin, G. M. https://orcid.org/0000-0001-9006-0768
Katerere, D. R. https://orcid.org/0000-0002-4606-294X
Funding

Funding for this research was provided by:

Tshwane University of Technology
License Information

Text and Data Mining valid from 2022-01-05

Version of Record valid from 2022-01-05
More Information

Article History

Received: 29 July 2021

Accepted: 1 December 2021

First Online: 5 January 2022

Declarations

:

: Prior to conducting the study, Ethics Approval was granted by the Faculty Committee for Postgraduate Studies and the Research Ethics Committee of Tshwane University of Technology on the 28 July 2016. The Ethics Committee for Research Ethics reference number given was FCRE: 2016/05/001 (3) (SCI). See Additional file . The study was conducted from 2016 to 2018. Invitations were sent to all stakeholders who participated (see Additional file for invitation letter) in the study and informed consent (see Additional file ) were given and signed by all before commencement of data collection in the second phase of the study.

: The authors declare that they have no competing interests.

Document is current